Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.57% | -2.54% | -1.26% | 0.39% | 3.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.57% | -2.54% | -1.26% | 0.39% | 3.10% |
| Cost of Revenue | -0.78% | -1.43% | -1.15% | 0.04% | 0.91% |
| Gross Profit | -3.31% | -3.00% | -1.31% | 0.53% | 4.04% |
| SG&A Expenses | -1.60% | -3.26% | -1.54% | -3.76% | -2.07% |
| Depreciation & Amortization | -6.81% | -0.45% | 10.82% | 21.02% | 36.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.48% | -3.67% | -1.23% | -0.23% | 2.63% |
| Operating Income | 14.53% | 16.87% | 0.81% | 7.70% | 2.83% |
| Income Before Tax | 76.72% | -345.46% | -352.47% | 75.77% | 75.18% |
| Income Tax Expenses | -428.73% | -582.23% | 898.95% | 336.49% | 331.65% |
| Earnings from Continuing Operations | 79.38% | -334.44% | -354.35% | 75.47% | 74.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.38% | -334.44% | -354.35% | 75.47% | 74.97% |
| EBIT | 14.53% | 16.87% | 0.81% | 7.70% | 2.83% |
| EBITDA | -70.20% | -24.42% | -27.26% | 201.83% | 1,288.95% |
| EPS Basic | 79.86% | -322.06% | -338.55% | 76.58% | 76.07% |
| Normalized Basic EPS | 21.34% | 21.30% | 4.47% | 22.04% | 16.31% |
| EPS Diluted | 79.86% | -322.06% | -338.55% | 76.58% | 76.07% |
| Normalized Diluted EPS | 21.34% | 21.30% | 4.47% | 22.04% | 16.31% |
| Average Basic Shares Outstanding | 3.77% | 3.86% | 3.64% | 3.23% | 2.79% |
| Average Diluted Shares Outstanding | 3.77% | 3.86% | 3.64% | 3.23% | 2.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |